Dexmedetomidine Versus Midazolam for Intensive Care Sedation of Children
Status:
Unknown status
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
Dexmedetomidine will be tested against midazolam in a prospective, randomized, double-blind
study of intensive care children, age 2-17 years.
The investigators' primary hypothesis is that time from end of medication to extubation will
be shorter with dexmedetomidine sedation.